Liminatus Pharma (Iris Acquisition) ^{Priced, Nasdaq: LIMN}

We are a blank check company. Our sponsor is affiliated with Tribe Capital Management LLC ("TCM"), a registered investment advisor. Tribe Capital Growth Corp I is a natural extension of TCM's core mission that will allow us to enter into long-term partnerships with companies that are ready to go public in the same way we partner with private companies that are looking to grow exponentially. Our purpose is to pursue opportunities with top-decile private technology companies that are exhibiting inflection points in their growth, with the potential to scale towards outsized outcomes with long-term venture capital. At TCM, we call these "N-of-1" opportunities, where a company has begun capturing a new atomic unit of value--like oil, idle cars, empty rooms, or the friend graph--that when captured, has the potential to catalyze an immense wave of innovation. The inflection point comes as the company has captured and begun to dominate the atomic unit, creating scarcity such that economic activity and entire markets refactor around the company. Tribe Arrow Holdings I is a company newly formed by TCM and Arrow Capital to be our sponsor. Arrow Capital ("Arrow") is a leading boutique asset manager and investment advisory firm.